User menu

Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: An update

Bibliographic reference Boon, Paul ; Engelborghs, Sebastiaan ; Hauman, Henri ; Jansen, An ; Lagae, Lieven ; et. al. Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: An update. In: Acta Neurologica Belgica, Vol. 112, no.2, p. 119-131 (2012)
Permanent URL http://hdl.handle.net/2078.1/131537
  1. Boon P, Engelborghs S, Hauman H, Jansen A, Lagae L, Legros B, Ossemann M, Sadzot B, Urbain E, van Rijckevorsel K (2008) Recommendations for the treatment of epilepsies in general practice in Belgium. Acta Neurol Belg 108:118–130
  2. Glauser Tracy, Ben-Menachem Elinor, Bourgeois Blaise, Cnaan Avital, Chadwick David, Guerreiro Carlos, Kalviainen Reetta, Mattson Richard, Perucca Emilio, Tomson Torbjorn, ILAE Treatment Guidelines: Evidence-based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes, 10.1111/j.1528-1167.2006.00585.x
  3. French J. A., Kanner A. M., Bautista J., Abou-Khalil B., Browne T., Harden C. L., Theodore W. H., Bazil C., Stern J., Schachter S. C., Bergen D., Hirtz D., Montouris G. D., Nespeca M., Gidal B., Marks W. J., Turk W. R., Fischer J. H., Bourgeois B., Wilner A., Faught R. E., Sachdeo R. C., Beydoun A., Glauser T. A., Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society, 10.1212/01.wnl.0000123693.82339.fc
  4. French J. A., Kanner A. M., Bautista J., Abou-Khalil B., Browne T., Harden C. L., Theodore W. H., Bazil C., Stern J., Schachter S. C., Bergen D., Hirtz D., Montouris G. D., Nespeca M., Gidal B., Marks W. J., Turk W. R., Fischer J. H., Bourgeois B., Wilner A., Faught R. E., Sachdeo R. C., Beydoun A., Glauser T. A., Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society, 10.1212/01.wnl.0000123695.22623.32
  5. Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults. A national clinical guideline. April 2003. ISBN:1 899893 58 X
  6. NHS. National Institute for Clinical Excellence. The epilepsies. The diagnosis and management of the epilepsies in adults and children in primary and secondary care. Clinical Guideline 20, October 2004. ISBN:1-84257-808-1
  7. Glauser Tracy A., Cnaan Avital, Shinnar Shlomo, Hirtz Deborah G., Dlugos Dennis, Masur David, Clark Peggy O., Capparelli Edmund V., Adamson Peter C., Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy, 10.1056/nejmoa0902014
  8. Brodie M. J., Perucca E., Ryvlin P., Ben-Menachem E., Meencke H.-J, , Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy, 10.1212/01.wnl.0000252941.50833.4a
  9. Kwan Patrick, Arzimanoglou Alexis, Berg Anne T., Brodie Martin J., Allen Hauser W., Mathern Gary, Moshé Solomon L., Perucca Emilio, Wiebe Samuel, French Jacqueline, Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies : Definition of Drug Resistant Epilepsy, 10.1111/j.1528-1167.2009.02397.x
  10. Toledano Rafael, Gil-Nagel Antonio, Adverse Effects of Antiepileptic Drugs, 10.1055/s-2008-1079336
  11. Berg Anne T., Berkovic Samuel F., Brodie Martin J., Buchhalter Jeffrey, Cross J. Helen, van Emde Boas Walter, Engel Jerome, French Jacqueline, Glauser Tracy A., Mathern Gary W., Moshé Solomon L., Nordli Douglas, Plouin Perrine, Scheffer Ingrid E., Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009, 10.1111/j.1528-1167.2010.02522.x
  12. Brodie Martin J., Sills Graeme J., Combining antiepileptic drugs—Rational polytherapy?, 10.1016/j.seizure.2011.01.004
  13. Lee Jong Woo, Dworetzky Barbara, Rational Polytherapy with Antiepileptic Drugs, 10.3390/ph3082362
  14. French Jacqueline A., Faught Edward, Rational polytherapy, 10.1111/j.1528-1167.2009.02238.x
  15. Perucca Emilio, Tomson Torbjörn, The pharmacological treatment of epilepsy in adults, 10.1016/s1474-4422(11)70047-3
  16. Panayiotopoulos CP (2010) A clinical guide to epileptic syndromes and their treatment. Revised second edition. Based on the ILAE classifications and practice parameter guidelines. Springer Healthcare, p 178
  17. Patsalos Philip N., Properties of Antiepileptic Drugs in the Treatment of Idiopathic Generalized Epilepsies, 10.1111/j.1528-1167.2005.00326.x
  18. Tatum WO (2010) Antiepileptic drugs: adverse effects and drug interactions. Neurology 16(3):136–158 (Continuum: Lifelong Learning in Neurology)
  19. Cramer Joyce A, Mintzer Scott, Wheless James, Mattson Richard H, Adverse effects of antiepileptic drugs: a brief overview of important issues, 10.1586/ern.10.71
  20. French Jacqueline A., Gazzola Deana M., New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?, 10.1177/2042098611411127
  21. Panayiotopoulos CP (2010) A clinical guide to epileptic syndromes and their treatment. Revised second edition. Based on the ILAE classifications and practice parameter guidelines. Springer Healthcare, pp 569–607
  22. Elger Christian E., Schmidt Dieter, Modern management of epilepsy: A practical approach, 10.1016/j.yebeh.2008.01.003
  23. Rowan A. J., Ramsay R. E., Collins J. F., Pryor F., Boardman K. D., Uthman B. M., Spitz M., Frederick T., Towne A., Carter G. S., Marks W., Felicetta J., Tomyanovich M. L., , New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine, 10.1212/01.wnl.0000167384.68207.3e
  24. Belcastro Vincenzo, Costa Cinzia, Galletti Francesca, Autuori Alessia, Pierguidi Laura, Pisani Francesco, Calabresi Paolo, Parnetti Lucilla, Levetiracetam in newly diagnosed late-onset post-stroke seizures: A prospective observational study, 10.1016/j.eplepsyres.2008.08.008
  25. Kutlu Gulnihal, Gomceli Yasemin B., Unal Yasemin, Inan Levent E., Levetiracetam monotherapy for late poststroke seizures in the elderly, 10.1016/j.yebeh.2008.04.025
  26. Lippa Carol F., Rosso Andrea, Hepler Marjorie, Jenssen Sigmund, Pillai Jyoti, Irwin David, Levetiracetam: A Practical Option for Seizure Management in Elderly Patients With Cognitive Impairment, 10.1177/1533317508325095
  27. García-Escrivá A, López-Hernández N (2007) Uso del levetiracetam en monoterapia en crisis postictus de la población anciana (The use of levetiracetam in monotherapy in post-stroke seizures in the elderly population). Rev Neurol 45:523–525
  28. Stefan H., Hubbertz L., Peglau I., Berrouschot J., Kasper B., Schreiner A., Krimmer J., Schauble B., , Epilepsy outcomes in elderly treated with topiramate, 10.1111/j.1600-0404.2008.01018.x
  29. Groselj J., Guerrini R., Van Oene J., Lahaye M., Schreiner A., Schwalen S., , Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy, 10.1111/j.1600-0404.2005.00469.x
  30. Runge U., Schaeuble B., Rettig K., Schreiner A., Topiramat - Initiale Monotherapie bei älteren Patienten mit Epilepsie, 10.1055/s-2007-970804
  31. Kutluay Ekrem, McCague Kevin, D’Souza Joseph, Beydoun Ahmad, Safety and tolerability of oxcarbazepine in elderly patients with epilepsy, 10.1016/s1525-5050(03)00037-4
  32. Dogan Ebru Apaydın, Usta Burcu Ekmekci, Bilgen Rengin, Senol Yesim, Aktekin Berrin, Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: A prospective study ın adult and elderly patients with newly diagnosed partial epilepsy, 10.1016/j.yebeh.2008.02.001
  33. Freidel M., Krause E., Kuhn K., Peper R., Vogel H., Oxcarbazepin in der Epilepsietherapie, 10.1055/s-2006-932218
  34. Harden Cynthia L., Hopp Jennifer, Ting Tricia Y., Pennell Page B., French Jacqueline A., Allen Hauser W., Wiebe Samuel, Gronseth Gary S., Thurman David, Meador Kimford J., Koppel Barbara S., Kaplan Peter W., Robinson Julian N., Gidal Barry, Hovinga Collin A., Wilner Andrew N., Vazquez Blanca, Holmes Lewis, Krumholz Allan, Finnell Richard, Le Guen Claire, Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency, 10.1111/j.1528-1167.2009.02128.x
  35. Harden Cynthia L., Meador Kimford J., Pennell Page B., Allen Hauser W., Gronseth Gary S., French Jacqueline A., Wiebe Samuel, Thurman David, Koppel Barbara S., Kaplan Peter W., Robinson Julian N., Hopp Jennifer, Ting Tricia Y., Gidal Barry, Hovinga Collin A., Wilner Andrew N., Vazquez Blanca, Holmes Lewis, Krumholz Allan, Finnell Richard, Hirtz Deborah, Le Guen Claire, Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes, 10.1111/j.1528-1167.2009.02129.x
  36. Harden Cynthia L., Pennell Page B., Koppel Barbara S., Hovinga Collin A., Gidal Barry, Meador Kimford J., Hopp Jennifer, Ting Tricia Y., Hauser W. A., Thurman David, Kaplan Peter W., Robinson Julian N., French Jacqueline A., Wiebe Samuel, Wilner Andrew N., Vazquez Blanca, Holmes Lewis, Krumholz Allan, Finnell Richard, Shafer Patricia O., Le Guen Claire L., Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding, 10.1111/j.1528-1167.2009.02130.x
  37. Mølgaard-Nielsen Ditte, Hviid Anders, Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects, 10.1001/jama.2011.624
  38. Tomson Torbjörn, Battino Dina, Bonizzoni Erminio, Craig John, Lindhout Dick, Sabers Anne, Perucca Emilio, Vajda Frank, Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry, 10.1016/s1474-4422(11)70107-7
  39. Abstracts, 10.1002/pds.2206
  40. Vajda FJ, Horgan D, Hollingworth S, Graham J, Hitchcock AA, Roten A, et al (2011) The prescribing of antiepileptic drugs for pregnant Australian women. Aust NZ J Obstet Gynaecol. doi: 10.1111/j.1479-828X.2011.01359.x
  41. Tomson Torbjörn, Battino Dina, Antiepileptic Treatment in Pregnant Women: Morphological and Behavioural Effects, Pediatric Clinical Pharmacology (2011) ISBN:9783642201943 p.295-315, 10.1007/978-3-642-20195-0_15
  42. Bromley Rebecca L., Mawer George, Love Jenna, Kelly James, Purdy Laura, McEwan Lauren, Briggs Maria, Smith Jill Clayton, Sin Xin, Baker Gus A, Early cognitive development in children born to women with epilepsy: A prospective report : Early Cognitive Development, 10.1111/j.1528-1167.2010.02668.x
  43. Shallcross R., Bromley R. L., Irwin B., Bonnett L. J., Morrow J., Baker G. A., , Child development following in utero exposure: Levetiracetam vs sodium valproate, 10.1212/wnl.0b013e3182088297
  44. Committee for medicinal Products for Human Use (CHMP). Guideline on the investigation of bioequivalence. CPMP/EWP/QWP/1401/98 Rev. 1/Corr. (20 January 2010)
  45. Krauss Gregory L., Caffo Brian, Chang Yi-Ting, Hendrix Craig W., Chuang Kelly, Assessing bioequivalence of generic antiepilepsy drugs, 10.1002/ana.22452
  46. Trinka Eugen, Krämer Günter, Graf Martin, Requirements for generic antiepileptic medicines: a clinical perspective, 10.1007/s00415-011-6126-6
  47. Chaluvadi Siresha, Chiang Sharon, Tran Larry, Goldsmith Corey E., Friedman David E., Clinical experience with generic levetiracetam in people with epilepsy : Generic Levetiracetam in PWES, 10.1111/j.1528-1167.2011.03025.x
  48. Sander Josemir W, Ryvlin Philippe, Stefan Hermann, Booth Daniel R, Bauer Jürgen, Generic substitution of antiepileptic drugs, 10.1586/ern.10.163
  49. Van Paesschen Wim, Hauman Henri, Lagae Lieven, The use of generic medication in epilepsy: A review of potential issues and challenges, 10.1016/j.ejpn.2008.07.007
  50. Belgisch Centrum voor farmacotherapeutische Informatie (Belgian Center for Pharmacotherapeutic Information). Gecommentarieerd Geneesmiddelen Repertorium (Annotated repertory of medicinal products). http://www.bcfi.be . Overschakelen van de ene specialiteit naar de andere (Switching from one brand to another) (February 2006)
  51. Belgisch Centrum voor Farmacotherapeutische Informatie (Belgian Center for Pharmacotherapeutic Information). Gecommentarieerd Geneesmiddelen Repertorium (Annotated repertory of medicinal products). http://www.bcfi.be . July 2011